NYBCe Opens New Cell and Gene Therapy Manufacturing Facility

Comprehensive Cell Solutions (CCS), a biotech division of New York Blood Center Enterprises (NYBCe), recently celebrated the grand opening of a new cell and gene therapy manufacturing facility at the University of Louisville Medical Center in Kentucky. The event, attended by NYBCe President and CEO Christopher D. Hillyer, MD, CCS leadership and university dignitaries, included a ribbon-cutting ceremony, facility tour and open house.

The 20,000-square-foot facility includes a new apheresis suite for patient and donor collections, a cell processing lab for minimal manipulation and a cell cryopreservation lab for intermediate products. It also features a microbiology lab, quality control labs, a material management warehouse, a cryopreservation storage room and two ISO 7 GMP cleanroom suites.

The Louisville facility joins existing CCS locations in Houston and New York City, enabling the organization to better serve biopharma companies, academic researchers, and treatment centers with cell sourcing, cryopreservation, and cell therapy manufacturing services. CCS also operates cell collection suites and apheresis services in Providence, R.I., Kansas City, Mo., and St. Paul, Minn.